日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PIK3CA gain-of-function mutation in Schwann cells leads to severe neuropathy and aerobic glycolysis through a non-cell autonomous effect.

雪旺细胞中 PIK3CA 功能获得性突变通过非细胞自主效应导致严重的神经病变和有氧糖酵解

Venot Quitterie, Firpion Marina, Ladraa Sophia, Bayard Charles, Magassa Sato, Di Guardo Roberta, Fraissenon Antoine, Hoguin Clément, Protic Sanela, Morin Gabriel, Mayeux Franck, Gourdon Genevieve, Fraitag Sylvie, Balducci Estelle, Kaltenbach Sophie, Villarese Patrick, Asnafi Vahid, Viel Thomas, Autret Gwennhael, Tavitian Bertrand, Goudin Nicolas, Guibaud Laurent, Bolino Alessandra, Canaud Guillaume

Somatic PIK3R1 mutations in the iSH2 domain are accessible to PI3Kα inhibition.

iSH2 结构域中的体细胞 PIK3R1 突变可被 PI3Kα 抑制剂治疗

Morin Gabriel, Garneau Alexandre P, Bouzakher Nabiha, Ségot Louise, Fraissenon Antoine, Blondel Amélie, Petit Florence, Chopinet Caroline, Mayeux Franck, Fayoux Pierre, Dompmartin Anne, Bodemer Christine, Balducci Estelle, Kaltenbach Sophie, Villarese Patrick, Asnafi Vahid, Legendre Christophe, Broissand Christine, Fraitag Sylvie, Quelin Chloé, Goudin Nicolas, Guibaud Laurent, Canaud Guillaume

Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia

低剂量英菲替尼疗法是治疗软骨发育不全的有效策略。

Demuynck, Benoit; Shah, Bhavik P; Mayeux, Franck; Vasseur, Laurine; Barbault, Florent; Ding, Jixin; Paull, Morgan; Reddi, Tejaswini; Muslimova, Elena; Legeai-Mallet, Laurence